youtube_live
Q2 2027 earnings • in 5 days
See detailschevron_right
MDT:NYSE
Medtronic PLC
$100.61
arrow_downward
-0.08%(-0.080) 1D
$100.61
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 19, 4:00:03 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MDT...
Open
$100.50
High
$101.50
Low
$100.00
Mkt. cap
128.70B
Avg. vol.
17.80M
Volume
5.83M
Dividend
2.86%
Quarterly dividend
$0.72
Ex-dividend date
Sep 25, 2026
P/E ratio
24.76
52-wk high
$106.33
52-wk low
$73.31
EPS
$4.06
Beta
0.56
Shares outstanding
1.28B
No. of employees
95K
Open
$100.50
High
$101.50
Low
$100.00
Mkt. cap
128.70B
Avg. vol.
17.80M
Volume
5.83M
Dividend
2.86%
Quarterly dividend
$0.72
Ex-dividend date
Sep 25, 2026
P/E ratio
24.76
52-wk high
$106.33
52-wk low
$73.31
EPS
$4.06
Beta
0.56
Shares outstanding
1.28B
No. of employees
95K
News stories
From web sources and news partners
Zacks
·
3 hours ago
BSX's Weak Solvency and Cash Conversion Raise Financing Risk
Zacks
·
8 hours ago
Ahead of Medtronic (MDT) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Benzinga
·
8 hours ago
Aecom To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday
Trefis
·
11 hours ago
How Much Did Medtronic Stock Really Pay Its Holders?
Profile
Medtronic plc is an international medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOGeoffrey S. Martha
Employees95K
Founded1949
Headquarters-
SectorHealth Care
IndustryMedical device
Websitemedtronic.com
Analyst ratings
Based on 20 analysts giving stock ratings to MDT in the past 3 months
Buy
Buy
12
Hold
8
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for MDT in the last 3 months.
Highest
Current $100.61
$120.00 (+19.27%)
Average
$107.24 (+6.59%)
Lowest
$92.00 (-8.56%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Mike Kratky Leerink Partners | Buy | Reiterated | $117.00 | +16.3% | 11/19/2026 |
Ryan Zimmerman BTIG | Buy | Maintained | $109.00 | +8.3% | 11/19/2026 |
Matthew O'Brien Piper Sandler | Buy | Upgraded | $120.00 | +19.3% | 11/17/2026 |
Travis Steed Bank of America Securities | Buy | Maintained | $120.00 | +19.3% | 11/16/2026 |
Robbie Marcus J.P. Morgan | Hold | Maintained | - | - | 10/16/2026 |
Christopher Pasquale Barclays | Hold | Initiated | $95.00 | -5.6% | 10/06/2026 |
Matt Miksic Barclays | Hold | Initiated | $95.00 | -5.6% | 10/06/2026 |
Joanne Wuensch Citi | Buy | Maintained | $110.00 | +9.3% | 10/05/2026 |
Kendall Au RBC Capital | Buy | Maintained | $118.00 | +17.3% | 10/01/2026 |
Josh Jennings TD Cowen | Buy | Reiterated | $110.00 | +9.3% | 09/30/2026 |
Michael Matson Needham | Buy | Maintained | $114.00 | +13.3% | 09/17/2026 |
Brandon Vazquez William Blair | Buy | Maintained | - | - | 09/10/2026 |
Larry Biegelsen Wells Fargo | Buy | Maintained | $104.00 | +3.4% | 09/09/2026 |
Pito Chickering Deutsche Bank | Hold | Reiterated | $92.00 | -8.6% | 09/03/2026 |
Patrick Wood UBS | Buy | Reiterated | $110.00 | +9.3% | 09/03/2026 |
Anthony Petrone Mizuho Securities | Buy | Reiterated | $115.00 | +14.3% | 09/02/2026 |
Jayson Bedford Raymond James | Hold | Maintained | - | - | 09/02/2026 |
Matthew Taylor Jefferies | Hold | Reiterated | $95.00 | -5.6% | 09/02/2026 |
Richard Newitter Truist Financial | Hold | Reiterated | $99.00 | -1.6% | 09/02/2026 |
Shagun Singh Chadha RBC Capital | Buy | Reiterated | $118.00 | +17.3% | 09/01/2026 |
Rick Wise Stifel Nicolaus | Hold | Maintained | $95.00 | -5.6% | 09/02/2026 |
David Rescott Robert W. Baird | Hold | Maintained | $100.00 | -0.6% | 09/02/2026 |
Priya Sachdeva UBS | Buy | Upgraded | $100.00 | -0.6% | 07/28/2026 |
Vijay Kumar Evercore ISI | Buy | Maintained | $105.00 | +4.4% | 07/06/2026 |
David Roman Goldman Sachs | Hold | Maintained | $83.00 | -17.5% | 06/04/2026 |
Lee Hambright Bernstein | Buy | Maintained | $97.00 | -3.6% | 06/04/2026 |
David Toung Argus Research | Buy | Maintained | $115.00 | +14.3% | 04/06/2026 |
Nico Chen DBS | Hold | Maintained | $90.00 | -10.5% | 03/18/2026 |
Unknown Analyst CICC | Buy | Initiated | $121.00 | +20.3% | 01/30/2026 |
Next call in 5 days
Tue, Nov 24, 2:30 PM
Fiscal period
Q2 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $1.33
Revenue / Est. (USD)
- / 9.48B
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
Revenue | 8.96B | 9.02B | 9.81B | 9.76B |
Cost of goods sold | 3.06B | 3.17B | 3.40B | 3.41B |
Cost of revenue | 3.06B | 3.17B | 3.40B | 3.41B |
Research and development expenses | 754.00M | 722.00M | 671.00M | 771.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.94B | 2.93B | 3.04B | 3.17B |
Operating expense | 4.08B | 4.04B | 4.25B | 4.48B |
Total operating expenses | 7.14B | 7.21B | 7.64B | 7.89B |
Operating income | 1.82B | 1.80B | 2.16B | 1.87B |
Other non operating income | 3.00M | 13.00M | 154.00M | 33.00M |
EBT including unusual items | 1.60B | 1.40B | 1.84B | 1.77B |
EBT excluding unusual items | 1.68B | 1.66B | 2.16B | 1.82B |
Income tax expense | 215.00M | 254.00M | 575.00M | 289.00M |
Effective tax rate | 13.47% | 18.10% | 31.34% | 16.35% |
Other operating expenses | -29.00M | -79.00M | 126.00M | 133.00M |
Net income | 1.37B | 1.14B | 1.24B | 1.47B |
Net profit margin | 15.33% | 12.68% | 12.68% | 15.07% |
Earnings per share | 1.36 | 1.36 | 1.55 | 1.45 |
Interest and investment income | 89.00M | 102.00M | 73.00M | 102.00M |
Interest expense | -181.00M | -181.00M | -176.00M | -186.00M |
Net interest expenses | -92.00M | -79.00M | -103.00M | -84.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 2.52B | 2.52B | 2.88B | 2.60B |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events